DeNA and Seibu Holdings helped Allm raise $180m, while several corporates are exiting ViaCyte in a $320m acquisition.

Allianz X helped digital insurance provider Coalition raise $250m while protein synthesis technology developer Nuclera hiked an E Ink-backed series B round to $58m.

Corporates are still investing in startups but valuations have fallen dramatically. Some areas such as China and healthcare have been hit hard.

Volkswagen and Ingka Group helped Northvolt secure over $1bn while Dai-ichi Life has led a $120m series C for YuLife.

Cambridge Enterprise has put cash into CardiaTec Biosciences in a pre-seed round that marks the inaugural deal for Laidlaw Scholars Ventures.

Insurance provider Uniqa's strategic investment arm has hired Kevin Seebacher as its latest investment manager.

Legend Capital led a $150m series E round for ClinChoice while Wemix took part in a $31.8m round for Planetarium Labs.

Mitsui Chemicals’ newly formed $36.8m 321Force unit will focus on healthcare, mobility, ICT and sustainable materials.

The nine-year Philips veteran is joining Ascension Ventures as medtech and life sciences investment leader.

The management change comes as OSF Ventures launches its third and biggest fund to date.